COVID-19 in hospitalized adult patients with sickle cell disease: A 2020 US cohort using Cerner Real-World Data (CRWD)

Guarino SH, Williams KD, Caplan RJ, Fawcett M, Lanzkron S J Clin Transl Sci 2023 ;7(1):e152 PMID: 37528938 Abstract We used Cerner Real-World Data™, representing hospital admission records from 2020, to examine patients with co-occurring sickle cell disease and COVID-19 by discharge disposition grouped as death/hospice versus transfers to other facilities, returned home, or left

Continue reading COVID-19 in hospitalized adult patients with sickle cell disease: A 2020 US cohort using Cerner Real-World Data (CRWD)

Adverse childhood experiences in children and adolescents with sickle cell disease: A retrospective cohort study

Pernell B, Nagalapuram V, Lebensburger J, Lin CP, Baskin ML, Pachter LM Pediatr Blood Cancer 2022 Mar;69(3):e29494 PMID: 34913574 Abstract BACKGROUND”>Adverse childhood experiences (ACEs) are linked to poor health outcomes; however, the relationship between ACEs and health outcomes among children and adolescents with sickle cell disease (SCD) has limited documentation in the published literature.</Abstr: Adverse

Continue reading Adverse childhood experiences in children and adolescents with sickle cell disease: A retrospective cohort study

Pediatric primary care clinicians’ views on needs and challenges in caring for infants with intrauterine opioid exposure and their families

Rohde JF, Canter K, Houff M, Bodt B, Pachter LM, Di Guglielmo MD, Goyal N J Child Health Care 2023 Apr;():13674935231168676 PMID: 37043307 Abstract Opioid use disorder (OUD) during pregnancy has risen in the U.S. over the past two decades, resulting in a growing number of children with intrauterine opioid exposure (IOE). Limited research exists

Continue reading Pediatric primary care clinicians’ views on needs and challenges in caring for infants with intrauterine opioid exposure and their families

Expanding the pediatrician’s black bag: a psychosocial care improvement model to address the “new morbidities”

Abatemarco DJ, Kairys SW, Gubernick RS, Kairys JA Jt Comm J Qual Patient Saf 2008 Feb;34(2):106-15 PMID: 18351195 Abstract BACKGROUND: Behavioral, developmental, and psychosocial problems (“new morbidities”) significantly affect the well-being of children ages 0-3 years. Practices generally fail to deliver consistent anticipatory guidance or counseling to parents. A multifaceted intervention was designed to increase

Continue reading Expanding the pediatrician’s black bag: a psychosocial care improvement model to address the “new morbidities”

Feasibility of a Novel COVID-19 Telehealth Care Management Program Among Individuals Receiving Treatment for Opioid Use Disorder: Analysis of a Pilot Program

Williams KD, Jurkovitz CT, Papas MA, Muther AK, Anderson SL, Anderson TL JMIR Form Res 2022 Aug;6(8):e39772 PMID: 35973033 Abstract BACKGROUND: The emergence of COVID-19 exacerbated the existing epidemic of opioid use disorder (OUD) across the United States due to the disruption of in-person treatment and support services. Increased use of technology including telehealth and

Continue reading Feasibility of a Novel COVID-19 Telehealth Care Management Program Among Individuals Receiving Treatment for Opioid Use Disorder: Analysis of a Pilot Program

Implementation of a clinical pathway to screen and treat medical inpatients for opioid withdrawal

Williams KD, Wilson BL, Jurkovitz CT, Melson JA, Reitz JA, Pal CK, Hausman SP, Booker E, Lang LJ, Horton TL Implement Res Pract ;3(): PMID: 35846074 Abstract Background: Opioid-related inpatient hospital stays are increasing at alarming rates. Unidentified and poorly treated opioid withdrawal may be associated with inpatients leaving against medical advice and increased health

Continue reading Implementation of a clinical pathway to screen and treat medical inpatients for opioid withdrawal

Mapping the Burden of Chronic Diseases in Delaware for Public Health Decision Making

McIntire RK, Brooks M, Siegel SD, , Papas M Dela J Public Health 2019 Feb;5(1):26-28 PMID: 34467011 Abstract Public health decision-makers need to consider geographic differences in rates of chronic disease risk factors and outcomes in order to focus intervention efforts on populations exhibiting the greatest burden of disease. Increasingly, public health agencies are using

Continue reading Mapping the Burden of Chronic Diseases in Delaware for Public Health Decision Making